Items where Funder is Cystic Fibrosis Trust.

Group by: Grant number | Institution | No Grouping

Jump to: 078606/Z/05/Z | 17855 | 18387 | 200923 | 223404 | 276 | 3T01 - 9203 | 9/R21/003 | 9R01/6002 | 9R11/6002 | 9R11/8006 | C23434/A23706 | G1001518 | LMBRU | M SPRAKES | MP/19269 | NO EXT REF GIVEN | NONE GIVEN | NOT GIVEN | R&D PP 1107 | RSC91 | SRC009 | SRC012

Number of items: 50.

078606/Z/05/Z

Ouboussad, L, Wong, C, Hunt, L et al. (3 more authors) (2016) A2.40 Investigating IL-6 pathway signalling kinetics in peripheral blood single cell subsets with tocilizumab therapy in patients with early rheumatoid arthritis. In: Annals of the Rheumatic Diseases. 36th European Workshop for Rheumatology Research, 25-27 Feb 2016, York, UK. BMJ Publishing Group , A31-A31.

17855

18387

200923

223404

276 3T01 - 9203

9/R21/003

9R01/6002

9R11/6002

9R11/8006

C23434/A23706

Birch, RJ orcid.org/0000-0003-1579-1397, Peckham, D orcid.org/0000-0001-7723-1868, Wood, HM orcid.org/0000-0003-3009-5904 et al. (7 more authors) (2022) The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study. Journal of Cystic Fibrosis. ISSN 1569-1993

G1001518

LMBRU

M SPRAKES

MP/19269

NO EXT REF GIVEN

NONE GIVEN

NOT GIVEN

R&D PP 1107

RSC91

SRC009

Scambler, T, Holbrook, J, Savic, S orcid.org/0000-0001-7910-0554 et al. (2 more authors) (2018) Autoinflammatory disease in the lung. Immunology, 154 (4). pp. 563-573. ISSN 0019-2805

Peckham, D orcid.org/0000-0001-7723-1868, McDermott, MF orcid.org/0000-0002-1015-0745, Savic, S orcid.org/0000-0001-7910-0554 et al. (1 more author) (2020) COVID-19 meets Cystic Fibrosis: for better or worse? Genes & Immunity, 21 (4). pp. 260-262. ISSN 1466-4879

Lara-Reyna, S, Holbrook, J orcid.org/0000-0001-8660-0282, Jarosz-Griffiths, HH orcid.org/0000-0001-5154-4815 et al. (2 more authors) (2020) Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations. Cellular and Molecular Life Sciences, 77 (22). pp. 4485-4503. ISSN 1420-682X

Scambler, T, Wong, CHI, Savic, S orcid.org/0000-0001-7910-0554 et al. (2 more authors) Inflammasome activation in cystic fibrosis bronchial epithelial cells is exacerbated in hypoxia. In: The 40th European Cystic Fibrosis Society Conference, 07-10 Jun 2017, Seville, Spain.

Aksentijevich, I and McDermott, MF orcid.org/0000-0002-1015-0745 (2017) Lessons from characterization and treatment of the inflammatory syndromes. Current Opinion in Rheumatology, 29 (2). pp. 187-194. ISSN 1040-8711

Lara-Reyna, S, Scambler, T, Holbrook, J et al. (6 more authors) (2019) Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation. Frontiers in Immunology, 10. 1789. ISSN 1664-3224

Clarke, EA, Taylor, J, Horsley, AR et al. (7 more authors) (2018) Musculoskeletal symptoms represent a significant burden for adults with cystic fibrosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2018, 01-03 May 2018, Liverpool, UK. Oxford Academic .

Lara Reyna, S orcid.org/0000-0002-9986-5279, Scambler, T, Holbrook, J et al. (6 more authors) (2018) Overactivation of IRE1α drives overexpression of IL-6 in cystic fibrosis. In: Pediatric Pulmonology. 32nd Annual North American Cystic Fibrosis Conference, 18-20 Oct 2018, Denver, CO, USA. Wiley , p. 189.

Clarke, EA, Ibrahim, M, Martin, K et al. (5 more authors) (2018) P130 Immunosuppression in cystic fibrosis: how worried should we be? In: Journal of Cystic Fibrosis 2018;17(3):S95–S96. 41ST European Cystic Fibrosis Society Conference, Belgrade, Serbia, 06-09 Jun 2018. Elsevier , S95-S96.

Jarosz-Griffiths, H orcid.org/0000-0001-5154-4815, Scambler, T, Holbrook, J et al. (5 more authors) (2018) S138 Inhibition of auto-inflammation in cystic fibrosis using small molecule therapy. In: Thorax. Winter Meeting of the British-Thoracic-Society, 05-07 Dec 2018, Westminster, England. BMJ Publishing Group , A86-A86.

Jarosz-Griffiths, HH orcid.org/0000-0001-5154-4815, Holbrook, J, Lara-Reyna, S et al. (1 more author) (2019) TNF receptor signalling in autoinflammatory diseases. International Immunology, 31 (10). pp. 369-348. ISSN 0953-8178

Scambler, T orcid.org/0000-0003-2468-0218, Wong, C, Pathak, S et al. (7 more authors) (2018) WS04.3 Sodium influx modulates innate immune inflammation and metabolism in cystic fibrosis. In: Journal of Cystic Fibrosis. 41st European Cystic Fibrosis Conference, 06-09 Jun 2018, Belgrade, Serbia. Elsevier BV , S8-S8.

Peckham, D orcid.org/0000-0001-7723-1868, Scambler, T, Savic, S orcid.org/0000-0001-7910-0554 et al. (1 more author) (2017) The burgeoning field of innate immune-mediated disease and autoinflammation. Journal of Pathology, 241 (2). pp. 123-139. ISSN 0022-3417

Jarosz-Griffiths, H orcid.org/0000-0001-5154-4815, Scambler, T, Lara Reyna, S orcid.org/0000-0002-9986-5279 et al. (7 more authors) (2019) ePS1.09 Inhibition of autoinflammation in cystic fibrosis using small molecule therapy. In: Journal of Cystic Fibrosis. 42nd European Cystic Fibrosis Conference, 05-08 Jun 2019, Liverpool, UK. Elsevier , S41.

Holbrook, J, Scambler, T, Lara Reyna, S orcid.org/0000-0002-9986-5279 et al. (5 more authors) (2018) The effect of cysteamine and epigallocatechin gallate on the inflammatory phenotype in cystic fibrosis. In: Pediatric Pulmonology. 32nd Annual North American Cystic Fibrosis Conference, 18-20 Oct 2018, Denver, CO, USA. Wiley , p. 245.

SRC012

Caley, L orcid.org/0000-0001-8957-1018, Smith, L, White, H et al. (1 more author) (2020) The Average Rate of Lung Function Decline in Adults with Cystic Fibrosis in the United Kingdom: Data from the UK CF Registry. In: To be confirmed. European Cystic Fibrosis Conference, 03-06 Jun 2020. . (In Press)

Caley, L orcid.org/0000-0001-8957-1018, Smith, L orcid.org/0000-0002-4280-6323, White, H et al. (1 more author) (2021) Average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: Data from the UK CF registry. Journal of Cystic Fibrosis, 20 (1). pp. 86-90. ISSN 1569-1993

Caley, L.R. orcid.org/0000-0001-8957-1018, Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Smith, L. orcid.org/0000-0002-4280-6323 et al. (11 more authors) (2023) Body mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis. Journal of Cystic Fibrosis, 22 (6). pp. 1002-1009. ISSN 1569-1993

Thu Dang, A, Begka, C, Pattaroni, C et al. (4 more authors) (2023) Butyrate regulates neutrophil homeostasis and impairs early antimicrobial activity in the lung. Mucosal Immunology. ISSN 1933-0219

Mainz, JG, Zagoya, C, Polte, L et al. (12 more authors) (2022) Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score. Frontiers in Pharmacology, 13. 877118. ISSN 1663-9812

Caley, L orcid.org/0000-0001-8957-1018 and Peckham, D orcid.org/0000-0001-7723-1868 (2022) Time to change course and tackle CF related obesity. Journal of Cystic Fibrosis, 21 (5). pp. 732-734. ISSN 1569-1993

Caley, L, Smith, L, White, H et al. (1 more author) (2020) WS23.3 The average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: data from the UK Cystic Fibrosis Registry. In: 43rd European Cystic Fibrosis Conference, 24-25 Sep 2020, Online.

Caley, L orcid.org/0000-0001-8957-1018, White, H, Jaudszus, A et al. (2 more authors) (2020) ePS2.03 Prevalence of gastrointestinal symptoms in pancreatic insufficient adults with cystic fibrosis: a UK cohort study. In: Journal of Cystic Fibrosis. 43rd European Cystic Fibrosis Conference, 2020, 24-25 Sep 2020, Online. Elsevier , S40-S40.

This list was generated on Fri May 3 04:22:21 2024 BST.

Export as	Atom RSS